Found 9 matching trials
An Efficacy, and Safety Study Of BXCL501 For The Treatment Of Agitation Associated With Dementia
PHASE2A randomized, double-blind, placebo-controlled parallel group 3-arm study a...
Location
Bioxcel Clinical Research Site
Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and Bipolar Disorder (SERENITY III)
PHASE3In this study, an investigational medication named BXCL501 is being tested ...
Location
BioXcel Clinical Research Site 113
Dexmedetomidine in the Treatment of Agitation Associated With Dementia (TRANQUILITY II)
PHASE3A study to determine the safety and efficacy of BXCL501 dosing for episodes...
Location
BioXcel Clinical Research Site
Sub-Lingual Dexmedetomidine in Agitation Associated With Dementia
PHASE1This is an adaptive Phase 1b/2 trial design. It is randomized, double-blind...
Location
BioXcel Clinical Research Site
Sub-Lingual Dexmedetomidine in Agitation Associated With Schizophrenia
PHASE1This is a two-stage adaptive Phase Ib trial design, that will identify two ...
Location
BioXcel Clinical Research Site
Study of BXCL501 In Agitation Associated With Delirium in ICU Patients
PHASE2This study is designed to determine and evaluate the optimal BXCL501 starti...
Location
BioXcel Clinical Research Site
Dexmedetomidine in the Treatment of Agitation Associated With Dementia (TRANQUILITY III)
PHASE3A study to determine the safety and efficacy of BXCL501 dosing for episodes...
Location
BioXcel Clinical Research Site
Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder
PHASE1This is a study of the efficacy and safety of BXCL501 in children and adole...
Location
BioXcel Clinical Research Site
Dexmedetomidine in the Treatment of Symptoms Of Acute Opioid Withdrawal
PHASE1This Phase 1b/2 inpatient study assessed the safety, pharmacokinetics, and ...
Location
BioXcel Clinical Research Site